115 related articles for article (PubMed ID: 28901082)
1. [Effect of Fuke Qianjin tablets on pharmacokinetics of Azithromycin in rats with chronic pelvic inflammatory disease].
Li W; Zou L; Gong Y; Zhang P; Wang P; Zhang Y; Qiu L
Zhongguo Zhong Yao Za Zhi; 2016 Jun; 41(12):2339-2343. PubMed ID: 28901082
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms of Fuke Qianjin Capsules in treatment of pelvic inflammatory disease based on GC-MS metabolomics].
Xia BH; Bai L; Zhang YS; Xiong SH; Li YM; Lin LM; Gong Y
Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(22):4940-4946. PubMed ID: 31872604
[TBL] [Abstract][Full Text] [Related]
3. [Meta-analysis on efficacy of Fuke Qianjin tablets (capsules) combined with antibiotics in treatment of endometritis].
Wang L; Xu R; Zhang SH; Ma SY; Xue YN
Zhongguo Zhong Yao Za Zhi; 2016 Aug; 41(16):3090-3095. PubMed ID: 28920354
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of Fuke Qianjin Capsules in treating intrauterine adhesion in rats through TGF-β1-PI3K/Akt signaling pathway].
Ya-Li T; Jia XU; Dong J; Zhi-Qiang HU; Lei L; Li-Mei L
Zhongguo Zhong Yao Za Zhi; 2020 Oct; 45(19):4705-4711. PubMed ID: 33164436
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, positive-controlled, Phase-II clinical trial to evaluate efficacy and safety of Fuke Qianjin capsule in Pakistani patients with pelvic inflammatory disease.
Shah MR; Khan SN; Fatima S; Yao L; Yuan H; Ullah S; Ainuddin J; Zeng C; Zheng Y; Sahar N; Anwar S; Zhu M; Ma C; Kumari K; Wang W; Liu R
Front Pharmacol; 2024; 15():1287321. PubMed ID: 38584600
[No Abstract] [Full Text] [Related]
6. Systematic Review and Meta-Analysis of Randomized Controlled Trials of Fuke Qianjin Tablet.
Jie P; Kai-Ni Z; Xiao-Mei W; Meng-Pei Z; Zhi-Heng W; Hao-Xiang Z; Wen-Tao Z
Evid Based Complement Alternat Med; 2021; 2021():8861631. PubMed ID: 33680066
[TBL] [Abstract][Full Text] [Related]
7. [Characteristic fingerprint and multi-components quantitative determination for Fuke Qianjin Capsules by HPLC].
Wang KH; Zhang YT; Yang XW; Xu W; Zhang P; Peng KF; Li FJ; Gong Y; Liu NF
Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1564-1572. PubMed ID: 31090320
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interaction between shuanghuanglian and azithromycin injection: a nonlinear mixed-effects model analysis in rats.
Tian J; Sun S; Zhao Z; Li X
Xenobiotica; 2019 Nov; 49(11):1344-1351. PubMed ID: 30457423
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin.
Chandra R; Liu P; Breen JD; Fisher J; Xie C; LaBadie R; Benner RJ; Benincosa LJ; Sharma A
Clin Pharmacokinet; 2007; 46(3):247-59. PubMed ID: 17328583
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis.
Wilms EB; Touw DJ; Heijerman HG
Ther Drug Monit; 2006 Apr; 28(2):219-25. PubMed ID: 16628134
[TBL] [Abstract][Full Text] [Related]
11. Azithromycin pharmacokinetics in the serum and its distribution to the skin in healthy dogs and dogs with pyoderma.
Zur G; Soback S; Weiss Y; Perry E; Lavy E; Britzi M
Vet J; 2014 Apr; 200(1):122-6. PubMed ID: 24472431
[TBL] [Abstract][Full Text] [Related]
12. Intravenous azithromycin.
Garey KW; Amsden GW
Ann Pharmacother; 1999 Feb; 33(2):218-28. PubMed ID: 10084418
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
[TBL] [Abstract][Full Text] [Related]
14. Determination of azithromycin in human plasma by LC-MS-MS and its pharmacokinetics.
Xue-Min Z; Jie L; Juan G; Quan-Sheng Y; Wen-Yan W
Pharmazie; 2007 Apr; 62(4):255-7. PubMed ID: 17484278
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetic and clinical evaluations of azithromycin in the pediatric field].
Okada T; Machida Y; Fujieda M; Shimazaki Y; Kurashige T
Jpn J Antibiot; 1996 Nov; 49(11):1024-9. PubMed ID: 8988414
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the bioequivalence of different formulations containing azithromycin (tablets and suspension).
Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):578-82. PubMed ID: 15497663
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of a single dose of sustained-release azithromycin formulation in pigeons.
Zań R; Burmańczuk A; Stępień-Pyśniak D; Gajda A; Gbylik-Sikorska M; Posyniak A; Kowalski C; Grabowski T
Pol J Vet Sci; 2020 Mar; 23(1):43-50. PubMed ID: 32233287
[TBL] [Abstract][Full Text] [Related]
18. [Comparative study of azithromycin pharmacokinetics in healthy volunteers in open cross randomized procedure].
Pisarev VV; Moskaleva NE; Zverkov IuB; Smirnova LB; Belolipetskaia VG; Sukhanov IaV
Antibiot Khimioter; 2003; 48(10):7-10. PubMed ID: 15004973
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetic and clinical studies on azithromycin in children].
Ohtsuka Y; Harada Y; Tsuji Y; Uehara Y; Kido T; Kobayashi N; Hayashi K
Jpn J Antibiot; 1996 Nov; 49(11):1039-48. PubMed ID: 8988416
[TBL] [Abstract][Full Text] [Related]
20. Effect of Ginkgo Leaf Tablets on the Pharmacokinetics of Amlodipine in Rats.
Wang R; Zhang H; Sun S; Wang Y; Chai Y; Yuan Y
Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):825-833. PubMed ID: 26650374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
